DARCY THOMAS E 4
4 · Forte Biosciences, Inc. · Filed Jan 14, 2021
Insider Transaction Report
Form 4
DARCY THOMAS E
DirectorExecutive Vice President
Transactions
- Exercise/Conversion
Common Stock
2021-01-13$9.59/sh+500$4,793→ 2,358 total - Exercise/Conversion
Stock Option (right to buy)
2021-01-13−500→ 0 totalExercise: $9.59Exp: 2021-06-15→ Common Stock (500 underlying)
Holdings
- 24,637(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The shares vest in a series of twelve (12) successive equal monthly installments measured from October 3, 2019. The option originally covered 7,500 shares pre 15-to-1 reverse stock split which became effective on June 15, 2020.
- [F2]The Form 4 filed October 4, 2019 incorrectly reported the Expiration Date as October 3, 2029. The correct Expiration Date is June 15, 2021.